Stanford Cancer Institute — Palo Alto, California

Public research footprint of Stanford Cancer Institute, compiled from the ClinicalTrials.gov public registry.

297

Registered studies

164

Active

Recruiting now

Completed

Stopped or withdrawn

Most-studied conditions

Metastatic Lung Non-Squamous Non-Small Cell Carcinoma · Chronic Lymphocytic Leukemia · Recurrent Endometrial Carcinoma · Stage IIIB Lung Cancer AJCC v8

Recently updated registry entries

NCT04269902 — Testing Early Treatment for Patients With High-Risk Chronic Lymphocytic Leukemia (CLL) or… (Recruiting)
NCT04267848 — Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy… (Recruiting)
NCT07277231 — A Study to Investigate Sonrotoclax (BGB-11417) Plus Zanubrutinib (BGB-3111) Compared With… (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Stanford Cancer Institute?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 07, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.